Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 698† | 592† | 1,273† | 1,185† | 1,030† |
| Net profit | 43 | 256 | 418 | 42 | -6† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Himanshu Jain | Executive Director | June 30, 2026 |
| Navrattan Munjal | Executive Director | June 30, 2026 |
| Rishav Mehta | Executive Director | June 30, 2026 |
| Sahil Munjal | Executive Director | June 30, 2026 |
| Neerja Chathley | Independent Director | June 30, 2026 |
| Rajinder Kumar Gupta | Independent Director | June 30, 2026 |
| Subodh Gupta | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
